Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Expression data from patient-derived xenograft (PDX) mouse models exposed to micvotabart pelidotin (MICVO) indicate gene signatures associated ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety ...

Humacyte's stock struggles despite FDA approval for Symvess, with financial concerns and slow adoption impacting future ...

Phase III VERITAC-2 trial results show vepdegestrant significantly improved progression-free survivalcompared to fulvestrant ...

March 25, 2025 expert reaction to study on first pig-to-human liver transplantation . A study published in Nature looks at a genetically modified pig-to-human liver transplantatio ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

In the late 90s, when email was still a novelty for many and before the term "fake news" had even made the news, an ominous ...

Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted ...

Combining BET inhibitors and PARP inhibitors might help patients resistant to chemotherapy, the study suggests.